Index by author
Rasmussen, Peter
- You have accessWhich patients benefit from carotid stenting? What recent trials showMark Bain, MD, Asma M. Moheet, MD and Peter Rasmussen, MDCleveland Clinic Journal of Medicine October 2008, 75 (10) 714-720;
Whether carotid stenting has any advantage over carotid surgery and which patients should undergo it are still topics of study and debate.
Schreiber, Martin J.
- You have accessPreventing renal disease progression: Can complete renin-angiotensin- aldosterone blockade work?Martin J. Schreiber, MDCleveland Clinic Journal of Medicine October 2008, 75 (10) 699-704;
In view of the risks of complete blockade of the renin-angiotensin- aldosterone pathway, more data from clinical trials are needed before the general medical community widely applies this strategy to prevent progressive chronic kidney disease.
Singer, Frederick R.
- You have accessUsing biochemical markers of bone turnover in clinical practiceFrederick R. Singer, MD and David R. Eyre, PhDCleveland Clinic Journal of Medicine October 2008, 75 (10) 739-750;
Although no guidelines to date recommend the widespread use of these markers in clinical practice, we believe they will eventually be accepted.
Stayman, Aaron
- You have accessA judgment callDeepak Asudani, MD, Sharon Wretzel, MD, Ruchita Patel, MD and Aaron Stayman, MDCleveland Clinic Journal of Medicine October 2008, 75 (10) 690-695;
A young man hospitalized because of a sickle cell crisis requires a central venous line. However, after the catheter is inserted, an initial chest radiograph reveals that the tip may not be in the right place. What should be done?
Wretzel, Sharon
- You have accessA judgment callDeepak Asudani, MD, Sharon Wretzel, MD, Ruchita Patel, MD and Aaron Stayman, MDCleveland Clinic Journal of Medicine October 2008, 75 (10) 690-695;
A young man hospitalized because of a sickle cell crisis requires a central venous line. However, after the catheter is inserted, an initial chest radiograph reveals that the tip may not be in the right place. What should be done?
Younossi, Zobair M.
- You have accessNonalcoholic fatty liver disease: A manifestation of the metabolic syndromeChin Hee Kim, MD and Zobair M. Younossi, MD, MPHCleveland Clinic Journal of Medicine October 2008, 75 (10) 721-728;
As we get heavier, our livers get fattier. Despite an explosion of research on nonalcoholic fatty liver disease and gains in understanding its epidemiology and pathogenesis, a number of issues remain unresolved, including how to treat it.